Old Web
English
Sign In
Acemap
>
Paper
>
182P Lenvatinib (LEN) plus anti-PD-1 antibodies vs LEN alone for advanced hepatocellular carcinoma (HCC): A real-world study
182P Lenvatinib (LEN) plus anti-PD-1 antibodies vs LEN alone for advanced hepatocellular carcinoma (HCC): A real-world study
2020
Qing Li
Minhu Chen
M Cao
G Yuan
X. Hu
W. Dai
M Zang
X. Cheng
J Huang
J. Hou
Jun Chen
Keywords:
anti pd 1
Antibody
Medicine
Oncology
Lenvatinib
Hepatocellular carcinoma
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]